Page last updated: 2024-08-05 15:04:52

Brassica napus metabolite

Any plant metabolite that is produced by rapeseed (Brassica napus).

ChEBI ID: 140165

Members (10)

MemberDefinitionClass
(E)-2-methoxycinnamic acidA member of the class of cinnamic acids that is trans-cinnamic acid carrying a methoxy substituent at position 2 on the benzene ring.(E)-2-methoxycinnamic acid
1,3-dicapryloylglycerolA 1,3-diglyceride in which both acyl groups are specified as octanoyl.1,3-dioctanoylglycerol
3-methoxybenzaldehydeA member of the class of benzaldehydes in which the hydrogen at position 3 of benzaldehyde has been replaced by a methoxy group.3-methoxybenzaldehyde
4',7-dihydroxyflavanoneA dihydroxyflavanone in which the two hydroxy substituents are located at positions 4' and 7.4',7-dihydroxyflavanone
5-methoxyindoleacetic acidA member of the class of indole-3-acetic acids in which the hydrogen at position 5 of indole-3-acetic acid has been replaced by a methoxy group.5-methoxyindole-3-acetic acid
5-methoxyresorcinolA member of the class of resorcinols that is phloroglucinol in which one of the phenolic hydrogens has been replaced by a methyl group.flamenol
8-nitroguanosine 3',5'-cyclic monophosphateA 3',5'-cyclic purine nucleotide that is guanosine 3',5'-cyclic monophosphate in which the hydrogen at position 8 on the purine fragment has been replaced by a nitro group.8-nitroguanosine 3',5'-cyclic monophosphate
carboxymethyl-coenzyme aAn S-alkyl-CoA having carboxymethyl as the S-alkyl component.carboxymethyl-CoA
eupatorinA trimethoxyflavone that is 6-hydroxyluteolin in which the phenolic hydogens at positions 4', 6 and 7 have been replaced by methyl groups.eupatorin
quercetin 3-o-gentiobiosideA quercetin O-glycoside in which the hydroxy hydrogen at position 3 of quercetin has been replaced by a gentiobiosyl group.quercetin 3-beta-gentiobioside

Research

Studies (197)

TimeframeStudies, Drugs with This Role(%)All Drugs %
pre-199035 (17.77)18.7374
1990's23 (11.68)18.2507
2000's27 (13.71)29.6817
2010's91 (46.19)24.3611
2020's21 (10.66)2.80

Study Types

Publication TypeStudies, Drugs with this Role (%)All Drugs (%)
Trials2 (0.93%)5.53%
Reviews20 (9.30%)6.00%
Case Studies2 (0.93%)4.05%
Observational0 (0.00%)0.25%
Other191 (88.84%)84.16%

Protein Targets (20)

Potency Measurements

ProteinTaxonomyMeasurementAverage (mM)Bioassay(s)Drugs
67.9K proteinVaccinia virusPotency0.501211
AR proteinHomo sapiens (human)Potency9.583722
aryl hydrocarbon receptorHomo sapiens (human)Potency13.333211
Chain A, 2-oxoglutarate OxygenaseHomo sapiens (human)Potency25.118911
cytochrome P450 family 3 subfamily A polypeptide 4Homo sapiens (human)Potency10.964011
estrogen nuclear receptor alphaHomo sapiens (human)Potency12.539722
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency26.779722
Fumarate hydrataseHomo sapiens (human)Potency3.981111
gemininHomo sapiens (human)Potency13.952022
GLS proteinHomo sapiens (human)Potency25.118911
nonstructural protein 1Influenza A virus (A/WSN/1933(H1N1))Potency2.511912
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency25.113111
peripheral myelin protein 22Rattus norvegicus (Norway rat)Potency10.181511
polyproteinZika virusPotency3.981111
RAR-related orphan receptor gammaMus musculus (house mouse)Potency11.883211
TDP1 proteinHomo sapiens (human)Potency16.788911

Inhibition Measurements

ProteinTaxonomyMeasurementAverage (mM)Bioassay(s)Drugs
Cytochrome P450 1A1Homo sapiens (human)Ki0.210011
Cytochrome P450 1B1Homo sapiens (human)Ki0.035022
Receptor-type tyrosine-protein kinase FLT3Homo sapiens (human)IC501.100011

Activation Measurements

ProteinTaxonomyMeasurementAverage (mM)Bioassay(s)Drugs
glycogen synthase kinase-3 beta isoform 1Homo sapiens (human)EC50300.000011